Cleared Traditional

K861119 - WALLANT NEUROLOGIX DUAL PUR NERVE/NEUROMUSCU STIMU

K861119 is an FDA 510(k) clearance for WALLANT NEUROLOGIX DUAL PUR NERVE/NEURO..., manufactured by Wallant Intl. Trade, Inc.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 161-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1986
Decision
161d
Days
Class 2
Risk

K861119 is an FDA 510(k) clearance for the WALLANT NEUROLOGIX DUAL PUR NERVE/NEUROMUSCU STIMU. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Wallant Intl. Trade, Inc. (Roselle, US). The FDA issued a Cleared decision on August 14, 1986 after a review of 161 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K861119

510(k) Number K861119 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 06, 1986
Decision Date August 14, 1986
Days to Decision 161 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
12d slower than avg
Panel avg: 149d · This submission: 161d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K861119.
UNI-TENS XL TENS
K861896 · Solcoor, Inc. · Sep 1986
TRANS-PULSE MODEL #1103
K862355 · The Sun Co. · Aug 1986
ULTRAPAC II SD (TM)
K862337 · Medical Devices, Inc. · Aug 1986
WALLANT NEUROLOGIX GENERAL PURPOSE TENS
K860847 · Wallant Intl. Trade, Inc. · Aug 1986
PULSAR NEUROSTIMULATOR
K852061 · Andromeda Research, Inc. · Jul 1986
EMPI MODEL GLS 450, TENS
K861830 · Empi · Jul 1986